Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial MyopathyAmel Karaa, Engelstad Kristin, Costanza Lamperti et al.|Neurology|2023Cited by 74
Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signalingAlexander M. Holtz, Benjamin A. Raby, Rachel VanCoillie et al.|Genetics in Medicine|2022Cited by 23
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trialAmel Karaa, Enrico Bertini, Valério Carelli et al.|Orphanet Journal of Rare Diseases|2024Cited by 11
Phenotypes of undiagnosed adults with actionable OTC and GLA variantsJessica I. Gold, Nina B. Gold, Sarina Madhavan et al.|Human Genetics and Genomics Advances|2023Cited by 3
Long‐Term Health Outcomes of Individuals With Pseudodeficiency Alleles in <scp> <i>IDUA</i> </scp> May Inform Newborn Screening Practices for Mucopolysaccharidosis Type ILauren O’Grady, Nina B. Gold, Hana Zouk et al.|American Journal of Medical Genetics Part A|2024Cited by 3